Roche: raises FY growth target

(CercleFinance.com) - Roche has announced that it now expects FY 2021 sales growth to be in the "mid-single digit" (instead of "low to mid-single digit growth) at constant exchange rates.


Core EPS is expected to grow broadly in line with sales at constant exchange rates. The Swiss healthcare group expects to further raise its dividend in Swiss francs.

9m sales of 46.7 billion Swiss francs rose 6% as reported and were up 8% at constant exchange rates, driven by a 39% increase in the diagnostics division, in part due to strong demand for Covid-19-related tests.


Copyright (c) 2021 CercleFinance.com. All rights reserved.